BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30126337)

  • 1. Impact of PET/CT on Staging and Treatment of Advanced Head and Neck Squamous Cell Carcinoma.
    Jorgensen JB; Smith RB; Coughlin A; Spanos WC; Lohr MM; Sperry SM; Militsakh O; Zitsch RP; Yueh B; Dooley LM; Panwar A; Galloway TLI; Pagedar NA
    Otolaryngol Head Neck Surg; 2019 Feb; 160(2):261-266. PubMed ID: 30126337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of
    Ha SC; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
    Acta Otolaryngol; 2019 Sep; 139(9):810-815. PubMed ID: 31274365
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of (18)F-FDG PET/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: A prospective observational study.
    Ryu IS; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2016 Aug; 63():88-96. PubMed ID: 27288873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis.
    Cacicedo J; Fernandez I; Del Hoyo O; Dolado A; Gómez-Suarez J; Hortelano E; Sancho A; Pijoan JI; Alvarez J; Espinosa JM; Gaafar A; Bilbao P
    Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1378-89. PubMed ID: 25952280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity.
    Linz C; Brands RC; Herterich T; Hartmann S; Müller-Richter U; Kübler AC; Haug L; Kertels O; Bley TA; Dierks A; Buck AK; Lapa C; Brumberg J
    JAMA Netw Open; 2021 Apr; 4(4):e217083. PubMed ID: 33881529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography scan on initial evaluation of head and neck squamous cell carcinoma: our experience at a tertiary care center in India.
    Nair S; Mohan S; Nilakantan A; Gupta A; Malik A; Gupta A
    World J Nucl Med; 2015; 14(1):19-24. PubMed ID: 25709540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?
    Dejaco D; Uprimny C; Widmann G; Riedl D; Moser P; Arnold C; Steinbichler TB; Kofler B; Schartinger VH; Virgolini I; Riechelmann H
    Cancer Imaging; 2020 Sep; 20(1):69. PubMed ID: 32993805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of diffusion-weighted imaging and
    Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
    Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of positron emission tomography/ computed tomography in the initial staging of head and neck squamous cell carcinoma: Accuracy in evaluation of the primary site of the tumor, metastases to cervical lymph nodes, and distant metastases.
    Krátká Z; Paska J; Kavka A; Jaruskova M; Lohynska R; Lickova K; Cocek A
    Otolaryngol Pol; 2022 Sep; 76(6):14-21. PubMed ID: 36805981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Diffusion-Weighted Imaging and
    Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-look PET-CT following an initial incomplete PET-CT response to (chemo)radiotherapy for head and neck squamous cell carcinoma.
    Prestwich RJD; Arunsingh M; Zhong J; Dyker KE; Vaidyanathan S; Scarsbrook AF
    Eur Radiol; 2020 Feb; 30(2):1212-1220. PubMed ID: 31485835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative
    Cho JK; Ow TJ; Lee AY; Smith RV; Schlecht NF; Schiff BA; Tassler AB; Lin J; Moadel RM; Valdivia A; Abraham T; Gulko E; Neimark M; Ustun B; Bello JA; Shifteh K
    Otolaryngol Head Neck Surg; 2017 Sep; 157(3):439-447. PubMed ID: 28608737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET/CT Versus Standard Imaging for Prediction of Survival in Patients with Recurrent Head and Neck Squamous Cell Carcinoma.
    Rohde M; Nielsen AL; Pareek M; Johansen J; Sørensen JA; Diaz A; Nielsen MK; Christiansen JM; Asmussen JT; Nguyen N; Gerke O; Thomassen A; Alavi A; Høilund-Carlsen PF; Godballe C
    J Nucl Med; 2019 May; 60(5):592-599. PubMed ID: 30315144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between PET/CT and CT in the staging prior to the treatment of head and neck squamous cell carcinoma.
    García-Curdi F; Lois-Ortega Y; Muniesa-Del Campo A; McGee-Laso A; Sebastián-Cortés JM; Vallés-Varela H; Lambea-Sorrosal JJ
    Braz J Otorhinolaryngol; 2021; 87(1):11-18. PubMed ID: 31337597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodal Imaging With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging to Detect Extracapsular Extension in Head and Neck Cancer.
    Sheppard SC; Giger R; Bojaxhiu B; Sachpekidis C; Dammann F; Dettmer MS; Arnold A; Wartenberg J; Nisa L
    Laryngoscope; 2021 Jan; 131(1):E163-E169. PubMed ID: 32142169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-treatment
    Jung AR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2020 Aug; 107():104750. PubMed ID: 32361565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Intensive 18F-Fludeoxyglucose-Positron Emission Tomography With Computed Tomography-Based Strategy of Follow-Up in Patients Treated for Head and Neck Squamous Cell Carcinoma Who Are Clinically Asymptomatic.
    Leclère JC; Clément C; Le Pennec R; Maheo C; Gujral DM; Schick U; Le Gal G; Marianowski R; Salaun PY; Abgral R
    JAMA Netw Open; 2023 Aug; 6(8):e2326654. PubMed ID: 37526935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of
    Jung JH; Lee SW; Son SH; Kim CY; Lee CH; Jeong JH; Jeong SY; Ahn BC; Lee J
    Head Neck; 2017 Mar; 39(3):447-455. PubMed ID: 27726225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
    Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
    Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study.
    Lonneux M; Hamoir M; Reychler H; Maingon P; Duvillard C; Calais G; Bridji B; Digue L; Toubeau M; Grégoire V
    J Clin Oncol; 2010 Mar; 28(7):1190-5. PubMed ID: 20124179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.